The Clinical Practices for Treatment of HIV Infection convened a 35-member panel in 1997 to examine clinical practice issues regarding HIV/AIDS treatment, resulting in a document on treatment guidelines. The controversial issues and the most likely sources of change that may occur during revisions of the document are reviewed. The issues that are reviewed include what constitutes no detectable virus in determining regimen effectiveness, what changes should be made in drug regimens that are considered failures, what to do when patients who are taking two nucleoside reverse transcriptase inhibitors have achieved the goal of undetectable virus, how to address the problems surrounding salvage therapy and the concept of class resistance among protease inhibitors, and the point at which antiretroviral therapy should be discontinued.
|Original language||English (US)|
|Number of pages||2|
|Journal||The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service|
|State||Published - Jan 1998|
ASJC Scopus subject areas